Number of Shares
44,400.00
Current Holdings Value*
kr2.97 Mil
% of Portfolio
0.74%
Total Estimate Gain
kr4.36 Mil
% of Total Estimate Gain
7.79%

Fidelity Advisor Overseas Fund's Novo Nordisk AS Holding Summary

As of 2025-04-30, FIDELITY ADVISOR SERIES VIII held 44,400.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr2.97 Mil. This investment constitutes 0.74% of their stock portfolio, and FIDELITY ADVISOR SERIES VIII now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2023Q1. And since then Fidelity Advisor Overseas Fund has made 4 purchases of OCSE:NOVO B, at an average price of kr487.28, for a total of 114,900.00 shares. In addition, there have been 5 sales at an average price of kr589.06 for 70,500.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Fidelity Advisor Overseas Fund's estimated gain on his OCSE:NOVO B holdings is kr4.36 Mil, reflecting a 7.79% gain to date.

Fidelity Advisor Overseas Fund OCSE:NOVO B (kr423.90) Holding Chart

Fidelity Advisor Overseas Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1